Our anti-emetics provide reliable effects to patients who experience nausea and vomiting as a side effect of chemotherapy, radiation, post-operative processes, and gastrointestinal disorders. The portfolio comprises 5-HT3 receptor antagonists such as ondansetron, dopamine antagonists such as metoclopramide, or NK1 receptor blockers. The products are customized to the hospital and homecare environment in tablet, syrups and injectable forms.